Skip to main content
MedPathMedPath Home
Clinical Trials/PACTR201409000782309
PACTR201409000782309
Completed
未知

Randomized open-label trial to evaluate the efficacy of artesunate-amodiaquin for seasonal malaria chemoprevention in suburban school of Bamako, Sirakoro-Meguetana, Mali

Malaria Research and Training Center/Faculty of Medecine and Dentistry/University of Sceinces, Techniques and Technologies0 sites200 target enrollmentMarch 5, 2014
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsMalaria

Overview

Phase
未知
Intervention
Not specified
Conditions
Malaria
Sponsor
Malaria Research and Training Center/Faculty of Medecine and Dentistry/University of Sceinces, Techniques and Technologies
Enrollment
200
Status
Completed
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 5, 2014
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Malaria Research and Training Center/Faculty of Medecine and Dentistry/University of Sceinces, Techniques and Technologies

Eligibility Criteria

Inclusion Criteria

  • •Children aged 6\-15 years;
  • •\- Enrolled in basic school Sirakoro Meguètana;
  • •\- Available and able to follow\-up study visits;
  • •\- Do not show any general danger signs (inability to drink, uncontrollable vomiting, history of convulsion, lethargy, inability to sit unaided) or other signs of severe and complicated malaria falciparum according to the criteria of WHO;
  • •\- Obtaining informed consent from child parents or guardian;
  • •\- No history of hypersensitivity reactions to study drugs reported ;

Exclusion Criteria

  • •\- Presence of biological abnormalities identified at enrollment
  • •\- Presence of any acute illness
  • •\- Presence of chronic diseases (diabetes, High blood pressure etc.).
  • •\- Presence of an evident pregnancy or revealed by a biological test
  • •\- History of antimalarial treatment (ACTs or other) within 15 days before enrollment

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Phase 1
An open-label randomized trial of zanidatamab for advanced HER2positive biliary tract cancer
CTIS2023-508219-21-00Jazz Pharmaceuticals Ireland Limited243
Not yet recruiting
Phase 3
An open-label randomized trial of zanidatamab for advanced HER2-positive biliary tract cancerHealth Condition 1: C249- Malignant neoplasm of biliary tract, unspecified
CTRI/2024/08/072371Jazz Pharmaceuticals Ireland Limited
Active, not recruiting
Phase 4
A trial to assess the efficacy of a new drug versus standard care for anaemia following colorectal cancer surgeryAnaemia with colorectal cancerCancer
ISRCTN12290106The Royal Wolverhampton NHS Trust42
Recruiting
Phase 4
Efficacy and safety evaluation of Suprotac® in comparison with Prograf® in prevention of liver transplant rejectioiver transplant.Liver transplant statusZ94.4
IRCT20150303021315N25anoalvand Company196
Completed
Not Applicable
A randomised open label trial to assess the efficacy, safety, and pharmacokinetic parameters of a fixed dose formulation of artesunate-mefloquine and standard dose artesunate and mefloquine as loose tablets for treatment of uncomplicated falciparum malaria (Thailand)MalariaInfections and Infestations
ISRCTN24192353Drugs for Neglected Diseases initiative (DNDi) (Switzerland)50